![Mitchell Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mitchell Glass
Directeur Technique/Scientifique/R&D chez
Q/C TECHNOLOGIES, INC.
Fortune : 29 000 $ au 31/08/2026
Profil
Dr. Mitchell Glass, MD, is a Director & Chief Medical Officer at Q/C Technologies, Inc., a Chairman at Accolade Pharma LLC and a Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd. He is on the Board of Directors at Q/C Technologies, Inc., Avatar Biotechnologies LLC, Orphagenix, Inc. and Chronic Airway Therapeutics Pty Ltd. Dr. Glass was previously employed as a Chief Medical Officer by Invion Ltd., a Chief Executive Officer by Aqumen Biopharmaceuticals NA, Inc., a Chief Scientific Officer by University City Science Center, a Chief Medical Officer & VP-Regulatory Affairs by AtheroGenics, Inc., a Director & Vice President by Smithkline Beecham Corp., a Principal by ICI Pharmaceuticals, a Chief Executive Officer by Aqumen Biopharmaceuticals KK, a Principal by Inverseon, Inc., a Chief Medical Officer & EVP-Research & Development by Invion Ltd., and a Principal by University of Pennsylvania.
He received his undergraduate degree from The University of Chicago and a doctorate degree from The University of Chicago.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Q/C TECHNOLOGIES, INC. 0,15 % | 13/04/2026 | 12 500 ( 0,15 % ) | 29 000 $ | 31/08/2026 |
Postes actifs de Mitchell Glass
| Sociétés | Poste | Début |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Directeur Technique/Scientifique/R&D | 13/06/2024 |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Président | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Directeur Général | - |
Avatar Biotechnologies LLC | Directeur/Membre du Conseil | 13/04/2010 |
Orphagenix, Inc. | Directeur/Membre du Conseil | 13/04/2010 |
Anciens postes connus de Mitchell Glass
| Sociétés | Poste | Fin |
|---|---|---|
| INVION LIMITED | Directeur Technique/Scientifique/R&D | 01/03/2019 |
| INVION LIMITED | Directeur/Membre du Conseil | 12/02/2019 |
Inverseon, Inc.
 Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Corporate Officer/Principal | 01/09/2012 |
Aqumen Biopharmaceuticals NA, Inc. | President | 02/01/2008 |
| ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mitchell Glass
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
98
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Orphagenix, Inc. | |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Aqumen Biopharmaceuticals NA, Inc. | |
Avatar Biotechnologies LLC | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MyMD Pharmaceuticals, Inc.
 MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Health Technology |
